Clinical Trial Update: Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a low-dose nifedipine-valsartan combination to up-titrated valsartan monotherapy in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Nifedipine-valsartan combination (nifedipine-valsartan)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 4 | Status: COMPLETED